Last reviewed · How we verify
NCT06620211: SCUPP
Evaluation of the Safety, Performance, and Tolerability of the Sacromesh® Medical Device in the Treatment of Prolapse by Promontofixation in a Population of Patients Followed Over the Long Term.
trial testing promontofixation, prolapse cure in Prolapse; Female in 290 participants. Completed in 19 October 2023.
19 October 2023
Quick facts
| Lead sponsor | Cousin Biotech |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 290 |
| Start date | 23 April 2020 |
| Primary completion | 19 October 2023 |
| Estimated completion | 19 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- promontofixation, prolapse cure
Conditions studied
- Prolapse; Female — all drugs for Prolapse; Female →
Sponsor
Cousin Biotech
Who can join
18 and older, female only, with Prolapse; Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An observational, multicenter study with retrospective recruitment and two data collection methods, one retrospective (medical records) and the other prospective (questionnaires). Patients who meet the inclusion criteria and have none of the non-inclusion criteria will be selected using the computer database of each investigating center. Data from consultation visits and surgery data will be collected and filled in the observation books. The patient will be contacted by the investigators to collect data on quality of life and the existence or absence of pain associated with implant placement at follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06620211
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prolapse; Female
Currently open trials in the same condition.
- NCT06404931 — Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment · Phase 2 · recruiting
- NCT05978414 — Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology · NA · recruiting
- NCT05836844 — Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical P · recruiting
- NCT04880239 — REDUCE Trial- Reducing Prolapse Recurrence · NA · recruiting
Other Cousin Biotech trials
Trials by the same sponsor.
- NCT05306496 — Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06620211 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cousin Biotech
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06620211.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing